The European Central Bank opened the door for further interest rate cuts. On Thursday, the European Central Bank cut interest rates for the fourth time this year and opened the door for further interest rate cuts in the future, because inflation is close to its target and the economy is still weak. The European Central Bank lowered the deposit interest rate from 3.25% to 3.0%, and cancelled the statement that the interest rate remained "sufficiently restrictive", suggesting that it was possible to cut interest rates further. The European Central Bank said: "The financial environment is easing, because the recent interest rate cuts by the European Central Bank have gradually reduced the new borrowing costs of enterprises and households." "But the financial environment is still very tight, because monetary policy is still restrictive, and past interest rate hikes are still being transmitted to outstanding stock credit."The news of the US stock market was delivered before the market. ① The three major stock index futures of the US stock market fell, and the market focused on PPI data. ② As of press time, Dow futures fell 0.19%, S&P 500 futures fell 0.18%, and Nasdaq futures fell 0.27%. (3) Germany's DAX index rose by 0.06%, Britain's FTSE 100 index rose by 0.11%, France's CAC40 index fell by 0.04% and Europe's Stoxx 50 index fell by 0.03%. ④WTI crude oil fell 0.06% to 70.25 USD/barrel. Brent crude oil fell 0.07% to $73.47/barrel. ⑤ American finance is under great pressure, with a budget deficit of $366.8 billion in November, up 17% year-on-year. ⑥ ING is bearish on the prospect of commodities next year, and gold is expected to outshine others. ⑦ Macy's department store fell 8.2% before the market, and the company lowered its profit outlook after discovering accounting errors. 8 Broadcom's share price rose by 4.3% before the market closed. In the news, Apple may cooperate with Broadcom to develop AI server chips. 9 ⑨Adobe's U.S. stocks fell by about 9% before the market, and the company's annual performance guidance was worse than expected.Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.
There are 695 listed companies in Jiangsu Province. According to the latest statistics of Jiangsu Listed Companies Association, there were 695 listed companies in Jiangsu Province by the end of November, including 15 new companies this year. Among the 695 companies, there are 216 main boards of Shanghai Stock Exchange, 110 in science and technology innovation board, 126 main boards of Shenzhen Stock Exchange (including one pure B-share), 196 Growth Enterprise Market and 47 North Stock Exchange. By geographical distribution, the total number of listed companies in Suzhou is far ahead in the province, reaching 219, 124 in Nanjing, 123 in Wuxi and 72 in Changzhou. In terms of A-shares, as of the end of November, there were 694 A-share listed companies in Jiangsu Province with a total market value of 6,745.231 billion yuan, accounting for 12.92% and 7.80% of the corresponding total of A-share listed companies respectively.The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.According to a poll released by The Israel Times recently, 66% of the Israeli respondents believe that Netanyahu should leave politics, and only 27% of the people support him.
Vassilis, a foreign exchange strategist, quickly commented on the ECB's resolution: the euro fell to a new low because the ECB gave up the "restrictive policy" part of the statement, but this does not mean that the policy language is downright dovish. Bonds in the euro zone are in a moderate trend.Tianyu Bio staged the "Heaven and Earth" market in the afternoon, with a turnover of over 900 million yuan.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
Strategy guide
12-14
Strategy guide
Strategy guide